Effectiveness of Monteleukast in treatment of Adenoid Hypertrophy in Childre

Phase 3

• Conditions: Adenoid Hypertrophy.; Hypertrophy of adenoids; J35.2

• Registration Number: IRCT20180718040520N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 April 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

hypertrophy of adenoids confirmed clinically and radiologically
Current use of nasal Mometason
No contraindication for corticosteroids or monteleukast
No previous adenoidectomy
Patients and parents consent
age 2 to 14 years

Exclusion Criteria

Allergic to nasal corticosteroids or antileukotriens
Craniofacial, neuromuscular disorders or syndromes
Acute upper respiratory tract infection
Use of corticosteroids or antibiotics within last 2 weeks
drug reactions requiring medication change
patients who require surgical treatment while participating
patient or parent refusal

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mouth breathing. Timepoint: before intervention and 1 months after and 2 months after intervention. Method of measurement: questionnaire.;Nasal Voice. Timepoint: before intervention and 1 months after and 2 months after intervention. Method of measurement: questionnaire.;Snoring. Timepoint: before intervention and 1 months after and 2 months after intervention. Method of measurement: questionnaire.